ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Sodium Hydroxide → HCID 11425299、化合物

HRID 1006380
ノート
印刷プレビュー

反応式

HRID 1006380 の反応式
Cl.[CH3:2][S:3]([C:6]1[CH:18]=[CH:17][C:9]([CH2:10][CH:11]2[CH2:16][CH2:15][NH:14][CH2:13][CH2:12]2)=[CH:8][CH:7]=1)(=[O:5])=[O:4].[OH-].[Na+]>O>[CH3:2][S:3]([C:6]1[CH:7]=[CH:8][C:9]([CH2:10][CH:11]2[CH2:12][CH2:13][NH:14][CH2:15][CH2:16]2)=[CH:17][CH:18]=1)(=[O:5])=[O:4]
参加物実験手順後処理出典と根拠反応ノート

参加物

4

反応物 2

HCID 14798Sodium HydroxideHCID 22676590HCID 22676590、化合物

生成物 1

HCID 11425299HCID 11425299、化合物収率 81.4%

試薬・触媒・溶媒 1

HCID 962Water溶媒

実験手順

4-[4-(Methylsulfonyl)benzyl]piperidine hydrochloride (1000 mg) was dissolved in water (10 mL). An aqueous solution of 1N sodium hydroxide (5 mL) was added to the solution at 0° C., and the aqueous phase was extracted with dichloromethane (10 mL×3). The organic phase was dried over potassium carbonate and filtered, and the filtrate was concentrated under reduced pressure. Diisopropyl ether (10 mL) was added to the residue, and the precipitate was collected by filtration. The precipitate was washed with diisopropyl ether and dried under reduced pressure to give the title compound as a white solid (712 mg).

後処理

  1. extractionthe aqueous phase was extracted with dichloromethane (10 mL×3)
  2. dry with materialThe organic phase was dried over potassium carbonate
  3. filtrationfiltered
  4. concentrationthe filtrate was concentrated under reduced pressure
  5. additionDiisopropyl ether (10 mL) was added to the residue
  6. filtrationthe precipitate was collected by filtration
  7. washThe precipitate was washed with diisopropyl ether
  8. customdried under reduced pressure

出典と根拠

ORDレコード
ord-f5d1f3b573ce4b709506ac8f422ba44e
出典データセット
uspto-grants-2004_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06787650B1

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート